Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma.
Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester, Strong Memorial Hospital, Rochester, NY. Electronic address: Melissalkp@gmail.com.
Kah Poh
KP
Loh
Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester, Strong Memorial Hospital, Rochester, NY.
Esther
E
Mondo
Department of Pharmacy, University of Rochester, Strong Memorial Hospital, Rochester, NY.
Elizabeth A
EA
Hansen
Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester, Strong Memorial Hospital, Rochester, NY.
Lynn
L
Sievert
Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester, Strong Memorial Hospital, Rochester, NY.
Chunkit
C
Fung
Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester, Strong Memorial Hospital, Rochester, NY.
Deepak M
DM
Sahasrabudhe
Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester, Strong Memorial Hospital, Rochester, NY.
Elizabeth
E
Guancial
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D023281:Genomics / Q000379:methods; D006801:Humans; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000235:genetics*
D000970:Antineoplastic Agents
Chemotherapy; Genomic alterations; Metastases; Next generation sequencing; Urachal cancer